Gelusil (WellSpring Pharmaceutical Corporation)


Welcome to the PulseAid listing for the Gelusil drug offered from WellSpring Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: WellSpring Pharmaceutical Corporation
NON-PROPRIETARY NAME: Alumina, Magnesia, Simethicone
SUBSTANCE NAME: ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE; DIMETHICONE; SILICON DIOXIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2008-09-24
END MARKETING DATE: 0000-00-00


Gelusil HUMAN OTC DRUG Details:

Item DescriptionGelusil from WellSpring Pharmaceutical Corporation
LABELER NAME: WellSpring Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 200; 24; 1(mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2008-09-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65197-300_93e9b420-4a75-4c6a-b552-36747fbe7b96
PRODUCT NDC: 65197-300
APPLICATION NUMBER: part331

Other ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE; DIMETHICONE; SILICON DIOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
WellSpring Pharmaceutical CorporationGelusil